Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4588 USD | +1.48% | +6.38% | -68.58% |
06/05 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
06/05 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-68.58% | 14.62M | |
-2.35% | 89.33B | |
+3.29% | 41.19B | |
-15.40% | 31.87B | |
+53.74% | 24.52B | |
-14.35% | 15.68B | |
-39.65% | 12.23B | |
-6.52% | 12.34B | |
-13.41% | 12.21B | |
+5.92% | 8.83B |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- RedHill Biopharma : HC Wainwright Trims Redhill Biopharma's Price Target to $21 From $23, Keeps Buy Rating